Global Radioactive Therapeutic Drugs Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Radioactive Therapeutic Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the Radioactive Therapeutic Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Radioactive Therapeutic Drugs market. Radioactive Therapeutic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Radioactive Therapeutic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Radioactive Therapeutic Drugs market.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
Key Features:
The report on Radioactive Therapeutic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Radioactive Therapeutic Drugs market. It may include historical data, market segmentation by Type (e.g., Oncology, Cardiology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Radioactive Therapeutic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Radioactive Therapeutic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Radioactive Therapeutic Drugs industry. This include advancements in Radioactive Therapeutic Drugs technology, Radioactive Therapeutic Drugs new entrants, Radioactive Therapeutic Drugs new investment, and other innovations that are shaping the future of Radioactive Therapeutic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Radioactive Therapeutic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Radioactive Therapeutic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Radioactive Therapeutic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Radioactive Therapeutic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Radioactive Therapeutic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Radioactive Therapeutic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Radioactive Therapeutic Drugs market.
Market Segmentation:
Radioactive Therapeutic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Radioactive Therapeutic Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the Radioactive Therapeutic Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Radioactive Therapeutic Drugs market. Radioactive Therapeutic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Radioactive Therapeutic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Radioactive Therapeutic Drugs market.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
Key Features:
The report on Radioactive Therapeutic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Radioactive Therapeutic Drugs market. It may include historical data, market segmentation by Type (e.g., Oncology, Cardiology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Radioactive Therapeutic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Radioactive Therapeutic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Radioactive Therapeutic Drugs industry. This include advancements in Radioactive Therapeutic Drugs technology, Radioactive Therapeutic Drugs new entrants, Radioactive Therapeutic Drugs new investment, and other innovations that are shaping the future of Radioactive Therapeutic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Radioactive Therapeutic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Radioactive Therapeutic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Radioactive Therapeutic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Radioactive Therapeutic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Radioactive Therapeutic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Radioactive Therapeutic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Radioactive Therapeutic Drugs market.
Market Segmentation:
Radioactive Therapeutic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Oncology
- Cardiology
- Others
- Hospitals
- Academic & Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Nihon Medi-Physics
- ITM Isotopen Technologien Mьnchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- GE Healthcare
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Lantheus Holdings, Inc.
- Curium Pharma
- Bayer AG
- Clarity Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioactive Therapeutic Drugs Market Size 2018-2029
2.1.2 Radioactive Therapeutic Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radioactive Therapeutic Drugs Segment by Type
2.2.1 Oncology
2.2.2 Cardiology
2.2.3 Others
2.3 Radioactive Therapeutic Drugs Market Size by Type
2.3.1 Radioactive Therapeutic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
2.4 Radioactive Therapeutic Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Academic & Research Institutes
2.4.3 Others
2.5 Radioactive Therapeutic Drugs Market Size by Application
2.5.1 Radioactive Therapeutic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
3 RADIOACTIVE THERAPEUTIC DRUGS MARKET SIZE BY PLAYER
3.1 Radioactive Therapeutic Drugs Market Size Market Share by Players
3.1.1 Global Radioactive Therapeutic Drugs Revenue by Players (2018-2023)
3.1.2 Global Radioactive Therapeutic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Radioactive Therapeutic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOACTIVE THERAPEUTIC DRUGS BY REGIONS
4.1 Radioactive Therapeutic Drugs Market Size by Regions (2018-2023)
4.2 Americas Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
4.3 APAC Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
4.4 Europe Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Radioactive Therapeutic Drugs Market Size by Country (2018-2023)
5.2 Americas Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
5.3 Americas Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioactive Therapeutic Drugs Market Size by Region (2018-2023)
6.2 APAC Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
6.3 APAC Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radioactive Therapeutic Drugs by Country (2018-2023)
7.2 Europe Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
7.3 Europe Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioactive Therapeutic Drugs by Region (2018-2023)
8.2 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOACTIVE THERAPEUTIC DRUGS MARKET FORECAST
10.1 Global Radioactive Therapeutic Drugs Forecast by Regions (2024-2029)
10.1.1 Global Radioactive Therapeutic Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Radioactive Therapeutic Drugs Forecast
10.1.3 APAC Radioactive Therapeutic Drugs Forecast
10.1.4 Europe Radioactive Therapeutic Drugs Forecast
10.1.5 Middle East & Africa Radioactive Therapeutic Drugs Forecast
10.2 Americas Radioactive Therapeutic Drugs Forecast by Country (2024-2029)
10.2.1 United States Radioactive Therapeutic Drugs Market Forecast
10.2.2 Canada Radioactive Therapeutic Drugs Market Forecast
10.2.3 Mexico Radioactive Therapeutic Drugs Market Forecast
10.2.4 Brazil Radioactive Therapeutic Drugs Market Forecast
10.3 APAC Radioactive Therapeutic Drugs Forecast by Region (2024-2029)
10.3.1 China Radioactive Therapeutic Drugs Market Forecast
10.3.2 Japan Radioactive Therapeutic Drugs Market Forecast
10.3.3 Korea Radioactive Therapeutic Drugs Market Forecast
10.3.4 Southeast Asia Radioactive Therapeutic Drugs Market Forecast
10.3.5 India Radioactive Therapeutic Drugs Market Forecast
10.3.6 Australia Radioactive Therapeutic Drugs Market Forecast
10.4 Europe Radioactive Therapeutic Drugs Forecast by Country (2024-2029)
10.4.1 Germany Radioactive Therapeutic Drugs Market Forecast
10.4.2 France Radioactive Therapeutic Drugs Market Forecast
10.4.3 UK Radioactive Therapeutic Drugs Market Forecast
10.4.4 Italy Radioactive Therapeutic Drugs Market Forecast
10.4.5 Russia Radioactive Therapeutic Drugs Market Forecast
10.5 Middle East & Africa Radioactive Therapeutic Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Radioactive Therapeutic Drugs Market Forecast
10.5.2 South Africa Radioactive Therapeutic Drugs Market Forecast
10.5.3 Israel Radioactive Therapeutic Drugs Market Forecast
10.5.4 Turkey Radioactive Therapeutic Drugs Market Forecast
10.5.5 GCC Countries Radioactive Therapeutic Drugs Market Forecast
10.6 Global Radioactive Therapeutic Drugs Forecast by Type (2024-2029)
10.7 Global Radioactive Therapeutic Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Nihon Medi-Physics
11.1.1 Nihon Medi-Physics Company Information
11.1.2 Nihon Medi-Physics Radioactive Therapeutic Drugs Product Offered
11.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Nihon Medi-Physics Main Business Overview
11.1.5 Nihon Medi-Physics Latest Developments
11.2 ITM Isotopen Technologien Mьnchen AG
11.2.1 ITM Isotopen Technologien Mьnchen AG Company Information
11.2.2 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product Offered
11.2.3 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 ITM Isotopen Technologien Mьnchen AG Main Business Overview
11.2.5 ITM Isotopen Technologien Mьnchen AG Latest Developments
11.3 Advanced Accelerator Applications
11.3.1 Advanced Accelerator Applications Company Information
11.3.2 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product Offered
11.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Advanced Accelerator Applications Main Business Overview
11.3.5 Advanced Accelerator Applications Latest Developments
11.4 Telix Pharmaceuticals
11.4.1 Telix Pharmaceuticals Company Information
11.4.2 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
11.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Telix Pharmaceuticals Main Business Overview
11.4.5 Telix Pharmaceuticals Latest Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Radioactive Therapeutic Drugs Product Offered
11.5.3 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 GE Healthcare Main Business Overview
11.5.5 GE Healthcare Latest Developments
11.6 Theragnostics Ltd.
11.6.1 Theragnostics Ltd. Company Information
11.6.2 Theragnostics Ltd. Radioactive Therapeutic Drugs Product Offered
11.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Theragnostics Ltd. Main Business Overview
11.6.5 Theragnostics Ltd. Latest Developments
11.7 NuView Life Sciences
11.7.1 NuView Life Sciences Company Information
11.7.2 NuView Life Sciences Radioactive Therapeutic Drugs Product Offered
11.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NuView Life Sciences Main Business Overview
11.7.5 NuView Life Sciences Latest Developments
11.8 Jubilant Pharma Limited
11.8.1 Jubilant Pharma Limited Company Information
11.8.2 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product Offered
11.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Jubilant Pharma Limited Main Business Overview
11.8.5 Jubilant Pharma Limited Latest Developments
11.9 Lantheus Holdings, Inc.
11.9.1 Lantheus Holdings, Inc. Company Information
11.9.2 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product Offered
11.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Lantheus Holdings, Inc. Main Business Overview
11.9.5 Lantheus Holdings, Inc. Latest Developments
11.10 Curium Pharma
11.10.1 Curium Pharma Company Information
11.10.2 Curium Pharma Radioactive Therapeutic Drugs Product Offered
11.10.3 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Curium Pharma Main Business Overview
11.10.5 Curium Pharma Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Radioactive Therapeutic Drugs Product Offered
11.11.3 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Information
11.12.2 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
11.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Clarity Pharmaceuticals Main Business Overview
11.12.5 Clarity Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioactive Therapeutic Drugs Market Size 2018-2029
2.1.2 Radioactive Therapeutic Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radioactive Therapeutic Drugs Segment by Type
2.2.1 Oncology
2.2.2 Cardiology
2.2.3 Others
2.3 Radioactive Therapeutic Drugs Market Size by Type
2.3.1 Radioactive Therapeutic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
2.4 Radioactive Therapeutic Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Academic & Research Institutes
2.4.3 Others
2.5 Radioactive Therapeutic Drugs Market Size by Application
2.5.1 Radioactive Therapeutic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
3 RADIOACTIVE THERAPEUTIC DRUGS MARKET SIZE BY PLAYER
3.1 Radioactive Therapeutic Drugs Market Size Market Share by Players
3.1.1 Global Radioactive Therapeutic Drugs Revenue by Players (2018-2023)
3.1.2 Global Radioactive Therapeutic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Radioactive Therapeutic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOACTIVE THERAPEUTIC DRUGS BY REGIONS
4.1 Radioactive Therapeutic Drugs Market Size by Regions (2018-2023)
4.2 Americas Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
4.3 APAC Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
4.4 Europe Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Radioactive Therapeutic Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Radioactive Therapeutic Drugs Market Size by Country (2018-2023)
5.2 Americas Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
5.3 Americas Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioactive Therapeutic Drugs Market Size by Region (2018-2023)
6.2 APAC Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
6.3 APAC Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radioactive Therapeutic Drugs by Country (2018-2023)
7.2 Europe Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
7.3 Europe Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioactive Therapeutic Drugs by Region (2018-2023)
8.2 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOACTIVE THERAPEUTIC DRUGS MARKET FORECAST
10.1 Global Radioactive Therapeutic Drugs Forecast by Regions (2024-2029)
10.1.1 Global Radioactive Therapeutic Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Radioactive Therapeutic Drugs Forecast
10.1.3 APAC Radioactive Therapeutic Drugs Forecast
10.1.4 Europe Radioactive Therapeutic Drugs Forecast
10.1.5 Middle East & Africa Radioactive Therapeutic Drugs Forecast
10.2 Americas Radioactive Therapeutic Drugs Forecast by Country (2024-2029)
10.2.1 United States Radioactive Therapeutic Drugs Market Forecast
10.2.2 Canada Radioactive Therapeutic Drugs Market Forecast
10.2.3 Mexico Radioactive Therapeutic Drugs Market Forecast
10.2.4 Brazil Radioactive Therapeutic Drugs Market Forecast
10.3 APAC Radioactive Therapeutic Drugs Forecast by Region (2024-2029)
10.3.1 China Radioactive Therapeutic Drugs Market Forecast
10.3.2 Japan Radioactive Therapeutic Drugs Market Forecast
10.3.3 Korea Radioactive Therapeutic Drugs Market Forecast
10.3.4 Southeast Asia Radioactive Therapeutic Drugs Market Forecast
10.3.5 India Radioactive Therapeutic Drugs Market Forecast
10.3.6 Australia Radioactive Therapeutic Drugs Market Forecast
10.4 Europe Radioactive Therapeutic Drugs Forecast by Country (2024-2029)
10.4.1 Germany Radioactive Therapeutic Drugs Market Forecast
10.4.2 France Radioactive Therapeutic Drugs Market Forecast
10.4.3 UK Radioactive Therapeutic Drugs Market Forecast
10.4.4 Italy Radioactive Therapeutic Drugs Market Forecast
10.4.5 Russia Radioactive Therapeutic Drugs Market Forecast
10.5 Middle East & Africa Radioactive Therapeutic Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Radioactive Therapeutic Drugs Market Forecast
10.5.2 South Africa Radioactive Therapeutic Drugs Market Forecast
10.5.3 Israel Radioactive Therapeutic Drugs Market Forecast
10.5.4 Turkey Radioactive Therapeutic Drugs Market Forecast
10.5.5 GCC Countries Radioactive Therapeutic Drugs Market Forecast
10.6 Global Radioactive Therapeutic Drugs Forecast by Type (2024-2029)
10.7 Global Radioactive Therapeutic Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Nihon Medi-Physics
11.1.1 Nihon Medi-Physics Company Information
11.1.2 Nihon Medi-Physics Radioactive Therapeutic Drugs Product Offered
11.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Nihon Medi-Physics Main Business Overview
11.1.5 Nihon Medi-Physics Latest Developments
11.2 ITM Isotopen Technologien Mьnchen AG
11.2.1 ITM Isotopen Technologien Mьnchen AG Company Information
11.2.2 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product Offered
11.2.3 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 ITM Isotopen Technologien Mьnchen AG Main Business Overview
11.2.5 ITM Isotopen Technologien Mьnchen AG Latest Developments
11.3 Advanced Accelerator Applications
11.3.1 Advanced Accelerator Applications Company Information
11.3.2 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product Offered
11.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Advanced Accelerator Applications Main Business Overview
11.3.5 Advanced Accelerator Applications Latest Developments
11.4 Telix Pharmaceuticals
11.4.1 Telix Pharmaceuticals Company Information
11.4.2 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
11.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Telix Pharmaceuticals Main Business Overview
11.4.5 Telix Pharmaceuticals Latest Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Radioactive Therapeutic Drugs Product Offered
11.5.3 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 GE Healthcare Main Business Overview
11.5.5 GE Healthcare Latest Developments
11.6 Theragnostics Ltd.
11.6.1 Theragnostics Ltd. Company Information
11.6.2 Theragnostics Ltd. Radioactive Therapeutic Drugs Product Offered
11.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Theragnostics Ltd. Main Business Overview
11.6.5 Theragnostics Ltd. Latest Developments
11.7 NuView Life Sciences
11.7.1 NuView Life Sciences Company Information
11.7.2 NuView Life Sciences Radioactive Therapeutic Drugs Product Offered
11.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NuView Life Sciences Main Business Overview
11.7.5 NuView Life Sciences Latest Developments
11.8 Jubilant Pharma Limited
11.8.1 Jubilant Pharma Limited Company Information
11.8.2 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product Offered
11.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Jubilant Pharma Limited Main Business Overview
11.8.5 Jubilant Pharma Limited Latest Developments
11.9 Lantheus Holdings, Inc.
11.9.1 Lantheus Holdings, Inc. Company Information
11.9.2 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product Offered
11.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Lantheus Holdings, Inc. Main Business Overview
11.9.5 Lantheus Holdings, Inc. Latest Developments
11.10 Curium Pharma
11.10.1 Curium Pharma Company Information
11.10.2 Curium Pharma Radioactive Therapeutic Drugs Product Offered
11.10.3 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Curium Pharma Main Business Overview
11.10.5 Curium Pharma Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Radioactive Therapeutic Drugs Product Offered
11.11.3 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Information
11.12.2 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
11.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Clarity Pharmaceuticals Main Business Overview
11.12.5 Clarity Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radioactive Therapeutic Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oncology
Table 3. Major Players of Cardiology
Table 4. Major Players of Others
Table 5. Radioactive Therapeutic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 8. Radioactive Therapeutic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 11. Global Radioactive Therapeutic Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Radioactive Therapeutic Drugs Revenue Market Share by Player (2018-2023)
Table 13. Radioactive Therapeutic Drugs Key Players Head office and Products Offered
Table 14. Radioactive Therapeutic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Radioactive Therapeutic Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Radioactive Therapeutic Drugs Market Size Market Share by Regions (2018-2023)
Table 19. Global Radioactive Therapeutic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Radioactive Therapeutic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Radioactive Therapeutic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Radioactive Therapeutic Drugs Market Size Market Share by Country (2018-2023)
Table 23. Americas Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 25. Americas Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 27. APAC Radioactive Therapeutic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Radioactive Therapeutic Drugs Market Size Market Share by Region (2018-2023)
Table 29. APAC Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 31. APAC Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 33. Europe Radioactive Therapeutic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Radioactive Therapeutic Drugs Market Size Market Share by Country (2018-2023)
Table 35. Europe Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 37. Europe Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Radioactive Therapeutic Drugs
Table 46. Key Market Challenges & Risks of Radioactive Therapeutic Drugs
Table 47. Key Industry Trends of Radioactive Therapeutic Drugs
Table 48. Global Radioactive Therapeutic Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Radioactive Therapeutic Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Radioactive Therapeutic Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Radioactive Therapeutic Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Nihon Medi-Physics Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 53. Nihon Medi-Physics Radioactive Therapeutic Drugs Product Offered
Table 54. Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Nihon Medi-Physics Main Business
Table 56. Nihon Medi-Physics Latest Developments
Table 57. ITM Isotopen Technologien Mьnchen AG Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 58. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product Offered
Table 59. ITM Isotopen Technologien Mьnchen AG Main Business
Table 60. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. ITM Isotopen Technologien Mьnchen AG Latest Developments
Table 62. Advanced Accelerator Applications Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 63. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product Offered
Table 64. Advanced Accelerator Applications Main Business
Table 65. Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Advanced Accelerator Applications Latest Developments
Table 67. Telix Pharmaceuticals Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 68. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
Table 69. Telix Pharmaceuticals Main Business
Table 70. Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Telix Pharmaceuticals Latest Developments
Table 72. GE Healthcare Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 73. GE Healthcare Radioactive Therapeutic Drugs Product Offered
Table 74. GE Healthcare Main Business
Table 75. GE Healthcare Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. GE Healthcare Latest Developments
Table 77. Theragnostics Ltd. Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 78. Theragnostics Ltd. Radioactive Therapeutic Drugs Product Offered
Table 79. Theragnostics Ltd. Main Business
Table 80. Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Theragnostics Ltd. Latest Developments
Table 82. NuView Life Sciences Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 83. NuView Life Sciences Radioactive Therapeutic Drugs Product Offered
Table 84. NuView Life Sciences Main Business
Table 85. NuView Life Sciences Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NuView Life Sciences Latest Developments
Table 87. Jubilant Pharma Limited Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 88. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product Offered
Table 89. Jubilant Pharma Limited Main Business
Table 90. Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Jubilant Pharma Limited Latest Developments
Table 92. Lantheus Holdings, Inc. Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 93. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product Offered
Table 94. Lantheus Holdings, Inc. Main Business
Table 95. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Lantheus Holdings, Inc. Latest Developments
Table 97. Curium Pharma Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 98. Curium Pharma Radioactive Therapeutic Drugs Product Offered
Table 99. Curium Pharma Main Business
Table 100. Curium Pharma Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Curium Pharma Latest Developments
Table 102. Bayer AG Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 103. Bayer AG Radioactive Therapeutic Drugs Product Offered
Table 104. Bayer AG Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Clarity Pharmaceuticals Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 108. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
Table 109. Clarity Pharmaceuticals Main Business
Table 110. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Clarity Pharmaceuticals Latest Developments
Table 1. Radioactive Therapeutic Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oncology
Table 3. Major Players of Cardiology
Table 4. Major Players of Others
Table 5. Radioactive Therapeutic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 8. Radioactive Therapeutic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 11. Global Radioactive Therapeutic Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Radioactive Therapeutic Drugs Revenue Market Share by Player (2018-2023)
Table 13. Radioactive Therapeutic Drugs Key Players Head office and Products Offered
Table 14. Radioactive Therapeutic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Radioactive Therapeutic Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Radioactive Therapeutic Drugs Market Size Market Share by Regions (2018-2023)
Table 19. Global Radioactive Therapeutic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Radioactive Therapeutic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Radioactive Therapeutic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Radioactive Therapeutic Drugs Market Size Market Share by Country (2018-2023)
Table 23. Americas Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 25. Americas Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 27. APAC Radioactive Therapeutic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Radioactive Therapeutic Drugs Market Size Market Share by Region (2018-2023)
Table 29. APAC Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 31. APAC Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 33. Europe Radioactive Therapeutic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Radioactive Therapeutic Drugs Market Size Market Share by Country (2018-2023)
Table 35. Europe Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 37. Europe Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Radioactive Therapeutic Drugs
Table 46. Key Market Challenges & Risks of Radioactive Therapeutic Drugs
Table 47. Key Industry Trends of Radioactive Therapeutic Drugs
Table 48. Global Radioactive Therapeutic Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Radioactive Therapeutic Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Radioactive Therapeutic Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Radioactive Therapeutic Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Nihon Medi-Physics Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 53. Nihon Medi-Physics Radioactive Therapeutic Drugs Product Offered
Table 54. Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Nihon Medi-Physics Main Business
Table 56. Nihon Medi-Physics Latest Developments
Table 57. ITM Isotopen Technologien Mьnchen AG Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 58. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product Offered
Table 59. ITM Isotopen Technologien Mьnchen AG Main Business
Table 60. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. ITM Isotopen Technologien Mьnchen AG Latest Developments
Table 62. Advanced Accelerator Applications Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 63. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product Offered
Table 64. Advanced Accelerator Applications Main Business
Table 65. Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Advanced Accelerator Applications Latest Developments
Table 67. Telix Pharmaceuticals Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 68. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
Table 69. Telix Pharmaceuticals Main Business
Table 70. Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Telix Pharmaceuticals Latest Developments
Table 72. GE Healthcare Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 73. GE Healthcare Radioactive Therapeutic Drugs Product Offered
Table 74. GE Healthcare Main Business
Table 75. GE Healthcare Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. GE Healthcare Latest Developments
Table 77. Theragnostics Ltd. Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 78. Theragnostics Ltd. Radioactive Therapeutic Drugs Product Offered
Table 79. Theragnostics Ltd. Main Business
Table 80. Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Theragnostics Ltd. Latest Developments
Table 82. NuView Life Sciences Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 83. NuView Life Sciences Radioactive Therapeutic Drugs Product Offered
Table 84. NuView Life Sciences Main Business
Table 85. NuView Life Sciences Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NuView Life Sciences Latest Developments
Table 87. Jubilant Pharma Limited Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 88. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product Offered
Table 89. Jubilant Pharma Limited Main Business
Table 90. Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Jubilant Pharma Limited Latest Developments
Table 92. Lantheus Holdings, Inc. Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 93. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product Offered
Table 94. Lantheus Holdings, Inc. Main Business
Table 95. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Lantheus Holdings, Inc. Latest Developments
Table 97. Curium Pharma Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 98. Curium Pharma Radioactive Therapeutic Drugs Product Offered
Table 99. Curium Pharma Main Business
Table 100. Curium Pharma Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Curium Pharma Latest Developments
Table 102. Bayer AG Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 103. Bayer AG Radioactive Therapeutic Drugs Product Offered
Table 104. Bayer AG Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Clarity Pharmaceuticals Details, Company Type, Radioactive Therapeutic Drugs Area Served and Its Competitors
Table 108. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product Offered
Table 109. Clarity Pharmaceuticals Main Business
Table 110. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Clarity Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Radioactive Therapeutic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radioactive Therapeutic Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radioactive Therapeutic Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radioactive Therapeutic Drugs Sales Market Share by Country/Region (2022)
Figure 8. Radioactive Therapeutic Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radioactive Therapeutic Drugs Market Size Market Share by Type in 2022
Figure 10. Radioactive Therapeutic Drugs in Hospitals
Figure 11. Global Radioactive Therapeutic Drugs Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Radioactive Therapeutic Drugs in Academic & Research Institutes
Figure 13. Global Radioactive Therapeutic Drugs Market: Academic & Research Institutes (2018-2023) & ($ Millions)
Figure 14. Radioactive Therapeutic Drugs in Others
Figure 15. Global Radioactive Therapeutic Drugs Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Radioactive Therapeutic Drugs Market Size Market Share by Application in 2022
Figure 17. Global Radioactive Therapeutic Drugs Revenue Market Share by Player in 2022
Figure 18. Global Radioactive Therapeutic Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Radioactive Therapeutic Drugs Value Market Share by Country in 2022
Figure 24. United States Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Radioactive Therapeutic Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Radioactive Therapeutic Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Radioactive Therapeutic Drugs Market Size Market Share by Application in 2022
Figure 31. China Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Radioactive Therapeutic Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Radioactive Therapeutic Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Radioactive Therapeutic Drugs Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Radioactive Therapeutic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radioactive Therapeutic Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radioactive Therapeutic Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radioactive Therapeutic Drugs Sales Market Share by Country/Region (2022)
Figure 8. Radioactive Therapeutic Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radioactive Therapeutic Drugs Market Size Market Share by Type in 2022
Figure 10. Radioactive Therapeutic Drugs in Hospitals
Figure 11. Global Radioactive Therapeutic Drugs Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Radioactive Therapeutic Drugs in Academic & Research Institutes
Figure 13. Global Radioactive Therapeutic Drugs Market: Academic & Research Institutes (2018-2023) & ($ Millions)
Figure 14. Radioactive Therapeutic Drugs in Others
Figure 15. Global Radioactive Therapeutic Drugs Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Radioactive Therapeutic Drugs Market Size Market Share by Application in 2022
Figure 17. Global Radioactive Therapeutic Drugs Revenue Market Share by Player in 2022
Figure 18. Global Radioactive Therapeutic Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Radioactive Therapeutic Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Radioactive Therapeutic Drugs Value Market Share by Country in 2022
Figure 24. United States Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Radioactive Therapeutic Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Radioactive Therapeutic Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Radioactive Therapeutic Drugs Market Size Market Share by Application in 2022
Figure 31. China Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Radioactive Therapeutic Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Radioactive Therapeutic Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Radioactive Therapeutic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Radioactive Therapeutic Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Radioactive Therapeutic Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Radioactive Therapeutic Drugs Market Size Market Share Forecast by Application (2024-2029)
